middle.news
Why Did Mayne Pharma Delay Filing a Director’s Interest Change for Over Three Years?
8:45am on Monday 12th of May, 2025 AEST
•
Healthcare
Read Story
Why Did Mayne Pharma Delay Filing a Director’s Interest Change for Over Three Years?
8:45am on Monday 12th of May, 2025 AEST
Key Points
Late Appendix 3Y filing for director Bruce Robinson's interest change
Delay attributed to administrative oversight and delayed information receipt
Mayne Pharma reviewing internal processes to prevent recurrence
Company reaffirms formal director agreements and disclosure policies
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Mayne Pharma (ASX:MYX)
OPEN ARTICLE